1 recruiting, 1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Apolipoprotein E, Deficiency or Defect of: new trials by email Literature Review of Apolipoprotein E, Deficiency or Defect of trials Research Report on Apolipoprotein E, Deficiency or Defect of
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults Alpha-Linolenic Acid (2.6 g/day), Placebo Control Group - Cognitive Dysfunction, Alzheimer Disease | Phase 2 | Recruiting | Michal Schnaider Beeri, Ph.D. | 20 | 2025-01-12 | 2026-02-06 |
| Perioperative Research Into Memory, Genomics in the Intensive Therapy Unit: Alzheimer's APOE genotyping - Cognitive Impairment, Apolipoprotein E, Deficiency or Defect of | Unknown | Chelsea and Westminster NHS Foundation Trust | 150 | 2018-02-01 | 2018-01-08 |
Cognitive Dysfunction (2) · Alzheimer Disease (1) · Burns (1) · Critical Illness (1) · Encephalitis (1) · Nerve Degeneration (1)
Brain Diseases (2) · Central Nervous System Diseases (2) · Cognition Disorders (2) · Mental Disorders (2) · Nervous System Diseases (2) · Neurocognitive Disorders (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Dementia (1) · Disease Attributes (1) · Neurodegenerative Diseases (1) · Neuroinflammatory Diseases (1) · Tauopathies (1) · Wounds and Injuries (1)
Corn Oil (1) · Linseed Oil (1) · alpha-Linolenic Acid (1)
Chelsea and Westminster NHS Foundation Trust (1) · Michal Schnaider Beeri, Ph.D. (1)
United States (1)